Anirvan Ghosh - 31 Jul 2023 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Chief Executive Officer
Signature
/s/ Alexander Nguyen, Attorney-in-Fact or Anirvan Ghosh
Issuer symbol
UBX
Transactions as of
31 Jul 2023
Net transactions value
-$2,917
Form type
4
Filing time
01 Aug 2023, 16:05:34 UTC
Previous filing
27 Jun 2023
Next filing
03 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Sale $2,917 -1,020 -1.2% $2.86 84,049 31 Jul 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 Includes Restricted Stock Units which vest over time measured from the grant date.